These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35560964)

  • 21. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.
    Weiss D; Klotz R; Govindan RB; Scholten M; Naros G; Ramos-Murguialday A; Bunjes F; Meisner C; Plewnia C; Krüger R; Gharabaghi A
    Brain; 2015 Mar; 138(Pt 3):679-93. PubMed ID: 25558877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side Effects.
    Romeo A; Dubuc DM; Gonzalez CL; Patel ND; Cutter G; Delk H; Guthrie BL; Walker HC
    Neuromodulation; 2019 Jun; 22(4):456-464. PubMed ID: 30844131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation of subthalamic nucleus modulates cortical auditory processing in advanced Parkinson's Disease.
    Valkonen K; Mäkelä JP; Airaksinen K; Nurminen J; Kivisaari R; Renvall H; Pekkonen E
    PLoS One; 2022; 17(2):e0264333. PubMed ID: 35202426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical beta burst dynamics are altered in Parkinson's disease but normalized by deep brain stimulation.
    Pauls KAM; Korsun O; Nenonen J; Nurminen J; Liljeström M; Kujala J; Pekkonen E; Renvall H
    Neuroimage; 2022 Aug; 257():119308. PubMed ID: 35569783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.
    Guo X; Gao G; Wang X; Li L; Li W; Liang Q; Zhang H
    Stereotact Funct Neurosurg; 2008; 86(4):237-44. PubMed ID: 18477840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease.
    Mahlknecht P; Akram H; Georgiev D; Tripoliti E; Candelario J; Zacharia A; Zrinzo L; Hyam J; Hariz M; Foltynie T; Rothwell JC; Limousin P
    Mov Disord; 2017 Aug; 32(8):1174-1182. PubMed ID: 28590508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease.
    Aman JE; Abosch A; Bebler M; Lu CH; Konczak J
    Mov Disord; 2014 Feb; 29(2):221-8. PubMed ID: 24243788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
    van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
    J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
    Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
    J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor symptom asymmetry in Parkinson's disease predicts emotional outcome following subthalamic nucleus deep brain stimulation.
    Voruz P; Le Jeune F; Haegelen C; N'Diaye K; Houvenaghel JF; Sauleau P; Drapier S; Drapier D; Grandjean D; Vérin M; Péron J
    Neuropsychologia; 2020 Jul; 144():107494. PubMed ID: 32413433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic nucleus conditioning reduces premotor-motor interaction in Parkinson's disease.
    Pauly MG; Barlage M; Hamami F; Steinhardt J; Baarbé J; Tran S; Hanssen H; Herzog R; Tadic V; Brüggemann N; Chen R; Münchau A; Bäumer T; Weissbach A
    Parkinsonism Relat Disord; 2022 Mar; 96():6-12. PubMed ID: 35093853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming.
    Frankemolle AM; Wu J; Noecker AM; Voelcker-Rehage C; Ho JC; Vitek JL; McIntyre CC; Alberts JL
    Brain; 2010 Mar; 133(Pt 3):746-61. PubMed ID: 20061324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep brain stimulation electrode position impact on parkinsonian non-motor symptoms.
    Bardon J; Kurcova S; Chudackova M; Otruba P; Krahulik D; Nevrly M; Kanovsky P; Zapletalova J; Valosek J; Hlustik P; Vastik M; Vecerkova M; Hvizdosova L; Mensikova K; Kurca E; Sivak S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Mar; 166(1):57-62. PubMed ID: 33883752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor effects of deep brain stimulation correlate with increased functional connectivity in Parkinson's disease: An MEG study.
    Boon LI; Hillebrand A; Potters WV; de Bie RMA; Prent N; Bot M; Schuurman PR; Stam CJ; van Rootselaar AF; Berendse HW
    Neuroimage Clin; 2020; 26():102225. PubMed ID: 32120294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.